Kymera Therapeutics Stock Performance
as on September 12, 2026 at 6:22 am IST
Day's Low
Day's High
$113.74$119.63
1.52%
Downside
3.58%
Upside
52 Week's Low
52 Week's High
$42.71$130.0563.03%
Downside
12.60%
Upside
Kymera Therapeutics share price movements today
- Previous Close
- $117.00
- Open
- $118.40
- Volume
- 322.5K
- Market Cap
- $9.6B
- Day's Low - High
- $113.74 - $119.63
- 52 Week Low - High
- $42.71 - $130.05
Kymera Therapeutics Historical Returns
- 1 Month Return
- + 6.31 %
- 3 Month Return
- + 47.55 %
- 1 Year Return
- + 165.48 %
- 3 Year Return
- + 509.45 %
- 5 Year Return
- + 73.16 %
Kymera Therapeutics Stock Fundamentals & Key Indicators
Check Kymera Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.6B
EPS (TTM)
-3.8149
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-339.9M
Revenue (TTM)
105.0M
Profit Margin
-285.33%
Return On Equity TTM
-24.15%
Kymera Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kymera Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $9.6B | 73.16% | NA | -285.33% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $138.4B | 181.2% | 30.54 | 86.04% | NA | |
| BUY | $56.0B | -69.82% | -16.99 | -12.57% | NA | |
| BUY | $85.2B | 24.16% | 19.28 | 84.86% | 45.660000000000004% |
Stock Returns calculator for Kymera Therapeutics Stock including INR - Dollar returns
The Kymera Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Kymera Therapeutics investment value today
Current value as on today
₹2,87,527
Returns
₹1,87,527
(+187.53%)
Returns from Kymera Therapeutics Stock
₹1,65,639 (+165.64%)
Dollar Impact
₹21,888 (+21.89%)
Analyst Recommendation on Kymera Therapeutics Stock
Based on 17 analysts
88.24%
Buy
11.76%
Hold
0.00%
Sell
Based on 17 analysts, 88.23529411764706% of analysts recommend a 'BUY' rating for Kymera Therapeutics. Average target price of $134.71
Kymera Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Kymera Therapeutics.
What analysts predicted
14.26%UPSIDE
Target Price
$134.71
Current Price
$115.5
Analyzed by
17 Analysts
Target
$134.71
Kymera Therapeutics target price $134.71, a slight upside of 14.26% compared to current price of $115.5. According to 17 analysts rating.
Indian Investors' Interest in Kymera Therapeutics Stock
Search interest for Kymera Therapeutics Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Kymera Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Kymera Therapeutics Annual Profit & Loss
All numbers in Millions USD
Kymera Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Kymera Therapeutics Annual Cash Flow
All numbers in Millions USD
Kymera Therapeutics News & Key Events
Today's Timeline - 27 July
Tue, 01:31 AM
-Kymera Therapeutics appoints Terence Rooney as Chief Medical Officer, succeeding Jared Gollob after eight years.
Insights on Kymera Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 2.76M → 64.99M (in $), with an average increase of 47.4% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, KYMR has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 months, KYMR stock has moved up by 41.0%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -87.02M → -61.21M (in $), with an average increase of 19.4% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 438.1% return, outperforming this stock by 284.9%
About Kymera Therapeutics
| Organisation | Kymera Therapeutics |
| Headquarters | 500 North Beacon Street, Watertown, MA, United States, 02472 |
| Industry | Biotechnology |
| CEO | Dr. Nello Mainolfi M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Kymera Therapeutics
Name | Title |
|---|---|
Dr. Nello Mainolfi M.D., Ph.D. | Co-Founder, President, CEO & Director |
Dr. Neil Graham M.D., M.P.H., MBBS | Chief Development Officer |
Mr. Brian Albarran M.B.A., Ph.D. | SVP of Corporate Strategy |
Dr. Juliet Williams B.A Ph.D. | Head of Research |
Dr. Jeremy G. Chadwick Ph.D. | Advisor |
Mr. Bruce N. Jacobs CFA | Chief Financial Officer |
Mr. Brian R. Adams J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Jared A. Gollob M.D. | Advisor |
Mr. Noah Goodman M.B.A. | Chief Business Officer |
Ms. Justine E. Koenigsberg | Vice President of Investor Relations |
FAQs
What is Kymera Therapeutics share price today?
Kymera Therapeutics share price today is $115.50 as on . Kymera Therapeutics share today touched a day high of $119.63 and a low of $113.74.
What is the 52 week high and 52 week low for Kymera Therapeutics share?
Kymera Therapeutics share touched a 52 week high of $130.05 on and a 52 week low of $42.71 on . Kymera Therapeutics stock price today i.e. is trending at $115.50,which is 11.19% down from its 52 week high and 170.46% up from its 52 week low.
What is Kymera Therapeutics's market capitalisation today?
Kymera Therapeutics market capitalisation is $0.01T as on .
How to invest in Kymera Therapeutics Stock (KYMR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kymera Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kymera Therapeutics Shares that will get you 0.0130 shares as per Kymera Therapeutics share price of $115.50 per share as on September 12, 2026 at 12:52 am IST.
What is the minimum amount required to buy Kymera Therapeutics Stock (KYMR) from India?
Indian investors can start investing in Kymera Therapeutics (KYMR) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Kymera Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kymera Therapeutics share’s latest price of $115.50 as on September 12, 2026 at 12:52 am IST, you will get 0.0866 shares of Kymera Therapeutics. Learn more about
fractional shares .
What are the returns that Kymera Therapeutics has given to Indian investors in the last 5 years?
Kymera Therapeutics stock has given 73.16% share price returns and 28.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?